Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Not applicable

Development of an Active Video-Based High-Intensity Interval Exercise System in Children With Asthma

NCT06895642 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2024-09-30
Last updated
2025-03-26

Condition(s) studied

Asthma in Children

Investigational drug(s) / intervention(s)

Exercise

Exercise: After all of the participants perform a symptom-limited cardiopulmonary exercise test, they included a single session high intensity interval exercise created according to test results. They randomized to two gorups as video and treadmill-based or only treadmill-based high intensity interval exercise.

Study summary

The aim of the study was to develop an active video-based high-intensity interval exercise system for the rehabilitation programs of children with asthma and to compare its immediate effects on heart rate variability, hemodynamic responses and thermal responses with a conventional high-intensity interval exercise.

Eligibility

Sex
ALL
Min age
8 Years
Max age
15 Years
Healthy volunteers
No
Inclusion Criteria: * Having asthma diagnosis according to GINA criteria * Being between 8-15 years of age * Having stabil asthma * Coming to routine follow-ups regularly * Being under regular pharmacological treatment and having good compliance with treatment confirmed by a physician * Volunteering to participate in the study (both child and parent) Exclusion Criteria: * Having another diagnosed chronic disease other than asthma * Obesity (Body mass index over 25 * Not having stable asthma defined as having had an exacerbation in the last 4 weeks * Having severe persistent asthma * Having exercise-induced asthma * Not being able to complete the exercise capacity test * Not being able to maintain the intensity of exercise ±5%

Primary outcome measure(s)

  • Heart rate variability — Before exercise immediately (in one minute), after exercise immediately (in one minute), and 5th and 10th minutes of the recovery period
    Heart rate variability will be measured in one minute immediately before exercise, in one minute immediately after exercise, and 5 and 10 minutes during recovery with Polar H10.
  • Heart rate — Before exercise immediately (in one minute), after exercise immediately (in one minute), and 5th and 10th minutes of the recovery period
    Heart rate will be measured in one minute immediately before exercise, in one minute immediately after exercise, and 5 and 10 minutes during recovery with Polar H10.

Trial sites (1)

FacilityCityRegionStatus
Manisa Celal Bayar University Manisa Manisa
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06895642 on ClinicalTrials.gov ↗ ← All trials in Turkey